相关实验视频
Updated: Jul 8, 2025

03:25
Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
5.5K
在1型糖尿病中使用连续葡萄糖监测数据共同预测食后低血糖和高血糖
概括
这项研究引入了一种新的机器学习模型,用于使用持续血糖监测 (CGM) 数据预测1型糖尿病 (T1DM) 中的高血糖和低血糖. 该模型取得了最先进的结果,为葡萄糖事件预测提供了一种简化和高效的方法.
科学领域:
- 生物医学工程 生物医学工程
- 人工智能在医学中的应用
- 糖尿病 技术 技术
背景情况:
- 持续血糖监测 (CGM) 系统为1型糖尿病患者 (T1DM) 提供实时血糖数据.
- 个性化葡萄糖预测对于管理T1DM和预防血糖偏差至关重要.
- 现有的研究往往只专注于预测低血糖症,忽视高血糖症.
研究的目的:
- 开发一种机器学习模型,用于在T1DM中联合预测食后高血糖和低血糖事件.
- 建立一个统一的预测框架,同时考虑高和低血糖水平.
- 创建一个广泛适用的模型,只使用CGM数据作为输入.
主要方法:
- 一个机器学习模型被设计成一个统一的骨干,同时预测高血糖和低血糖.
- 该模型从从CGM数据获得的过去1小时的葡萄糖序列中学习模式.
- 该方法只需要CGM时间序列数据,不包括营养信息等额外的输入.
主要成果:
- 拟议的模型在俄俄T1DM数据集上实现了最先进的性能.
- 获得了0.61的马修的相关系数,用于高血糖预测.
- 实现了马修的相关系数0.48,用于低血糖预测.
结论:
- 开发的模型提供了一种有效和计算效率高的方法,用于预测T1DM中的关节高血糖和低血糖.
- 该模型仅依赖于CGM数据,提高了其适用性和易于与现有系统集成的可能性.
- 该代码的开源发布旨在促进对糖尿病管理的个性化葡萄糖预测的进一步研究.
相关概念视频
Hypoglycemia and Glucagon
266
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
266
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes: Symptoms, Diagnosis, and Complications
554
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
554
Insulin: Dosing Regimen and Adverse Effects
179
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
179
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Diabetes: Management and Pharmacotherapy
288
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
288

